[On the position of butyrophenone derivative Triperidol in psychiatric treatment].
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002090:Butyrophenones / Q000008:administration & dosage / Q000627:therapeutic use*; D002389:Catatonia / Q000188:drug therapy; D002648:Child; D003863:Depression / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008607:Intellectual Disability / Q000188:drug therapy*; D008297:Male; D009155:Mutism / Q000188:drug therapy*; D009497:Neurotic Disorders / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy
D000928:Antidepressive Agents; D002090:Butyrophenones
Zur Stellung des Butyrophenon-Derivates Triperidol in der psychiatrischen Therapie.